Clinical Trial Update: AMH Dynamic Changes to Predict Ovarian Reserve in Perimenopausal Breast Cancer

View source ↗

Summary

This clinical trial update describes a study evaluating dynamic changes in anti-Müllerian hormone (AMH) to predict ovarian reserve in perimenopausal women with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ovarian Reserve
• Perimenopause

Snippet

Sponsor: Shengjing Hospital | Conditions: Breast Cancer, Perimenopause | Status: NOT_YET_RECRUITING